Distinct C/EBP functions are required for eosinophil lineage commitment and maturation

  1. Claus Nerlov1,
  2. Kelly M. McNagny1,3,
  3. Gabriele Döderlein1,
  4. Elisabeth Kowenz-Leutz2, and
  5. Thomas Graf1,4
  1. 1European Molecular Biology Laboratory (EMBL), D69117, Heidelberg, Germany; 2Max-Delbrück Center for Molecular Medicine, 13122 Berlin, Germany

Abstract

Hematopoietic differentiation involves the commitment of multipotent progenitors to a given lineage, followed by the maturation of the committed cells. To study the transcriptional events controlling these processes, we have investigated the role of C/EBP proteins in lineage choice of multipotent hematopoietic progenitors (MEPs) transformed by the E26 virus. We found that forced expression of either the α or β isoforms of C/EBP in MEPs induced eosinophil differentiation and that in addition, C/EBPβ could induce myeloid differentiation. Conversely, dominant-negative versions of C/EBPβ inhibited myeloid differentiation. C/EBP-induced eosinophil differentiation could be separated into two distinct events, lineage commitment and maturation. Thus, eosinophils induced by transactivation-deficient C/EBPβ alleles were found to be blocked in their maturation, whereas those expressing wild-type C/EBP proteins were not. Likewise, a 1-day activation of a conditional C/EBPβ allele in multipotent progenitors led to the formation of immature eosinophils, whereas sustained activation produced mature eosinophils. These results show that C/EBP can induce both myeloid and eosinophil lineage commitment and that transactivation independent and dependent C/EBP functions are required during eosinophil lineage commitment and maturation, respectively.

Keywords

Footnotes

  • 3 Present address: Biomedical Research Centre, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.

  • 4 Corresponding author.

  • E-MAIL graf{at}embl-heidelberg.de; FAX 49 6221 387 516.

    • Received February 17, 1998.
    • Accepted April 29, 1998.
| Table of Contents

Life Science Alliance